tbuckley/cabot-search huggingface dataset:
Specialty Board Certification Rates
Authors: Edithe J. Levit
Journal: JAMA (1978)

This study is follow-up analysis of increments in specialty board certification rates occurring between 1971 and 1976 for 2,046 physicians who graduated in 1960, 1964, and 1968. Data obtained at 8-, 12-, and 16-year intervals following graduation from medical school indicate that it is not until 12 years' following receipt of the MD degree that most physicians will have entered the certification process or be certified. An additional increment is found 16 years following graduation. At eight and 12 years following graduation, the more recent graduates showed a much higher rate of board certification than earlier graduates at a comparable interval following graduation. Of the total study population, 81% are either board certified or in the certification process. When two essentially office-based specialties are excluded, 92% of the study population have formally entered the certification process.
Scleredema of Buschke associated with rheumatoid arthritis and Sjogren's syndrome
Authors: S. MIYAGAWA, K. DOHI, S. TSURUTA, T. SHIRAI
Journal: British Journal of Dermatology (1989)

A case of scleredema of Buschke associated with rheumatoid arthritis and Sjögren's syndrome is described. The onset of the skin changes and rheumatoid arthritis was almost simultaneous and the sicca syndrome developed 4 years later.
Pacemaker in a Centenarian
Authors: Stephen G. Edelstein
Journal: JAMA (1971)

<h3>To the Editor.—</h3> Although the isolated case history method is not ideal for presenting statistically significant medical data, I believe that the case report of Colokathis et al confirms the findings of other investigators that age per se is no barrier to the benefit which may be derived from a permament transvenous pacemaker. For the purpose of general information, it seems only fitting to add our case of a 97-year-old man who had a permanent transvenous pacemaker inserted on July 10, 1969, with good results for approximately two months until the patient died on Sept 9 of a cerebral vascular accident. Since life expectancy at this advanced age is limited, it would be difficult to statistically prove the benefit derived from pacemaker therapy using survival time as the measure. However improved hemodynamic function can be judged by freedom syncopal episodes and a general improvement in the patient's physical and mental
Interim discharge summaries: how are they best delivered to general practitioners?
Authors: D A Sandler, J R Mitchell
Journal: BMJ (1987)

All patients discharged from a medical ward during four months were randomly assigned to one of two groups. In one group the patients were given their interim discharge summary for delivery to their general practitioner by hand; in the other group the summary was posted by the hospital. Of the 289 summaries sent by either method, 279 (97%) arrived at the general practitioner9s surgery. A mean (median) time of two (one) days elapsed before arrival when summaries were delivered by hand and a mean (median) of four and a half (four) days when they were posted; at least 55% of summaries delivered by hand arrived within one day of the day of discharge compared with 8% of those posted. If all interim discharge summaries were given to patients to deliver communication between hospitals and general practitioners would be accelerated and considerable savings might be made.
Incidence and Pathology of Synucleinopathies and Tauopathies Related to Parkinsonism
Authors: Rodolfo Savica, Brandon R. Grossardt, James H. Bower, J. Eric Ahlskog, Walter A. Rocca
Journal: JAMA Neurology (2013)

<h3>Importance</h3> The frequency and distribution of synucleinopathies and tauopathies manifesting with parkinsonism in the general population are poorly understood, thus affecting health care planning and research. <h3>Objective</h3> To investigate the incidence and distribution of specific types of parkinsonism and related proteinopathies. <h3>Design</h3> We used the medical records–linkage system of the Rochester Epidemiology Project to identify all subjects who received a screening diagnostic code related to parkinsonism in Olmsted County, Minnesota, from January 1, 1991, through December 31, 2005 (15 years). A movement disorders specialist reviewed the complete medical records of each subject who screened positive to determine the type of parkinsonism and the presumed proteinopathy using specified criteria. <h3>Setting</h3> Geographically defined population. <h3>Participants</h3> All residents of Olmsted County who provided authorization to use their data for medical records research (population-based sample). <h3>Main Outcome and Measures</h3> Incidence of parkinsonism and specific proteinopathies. <h3>Results</h3> Among 542 incident cases of parkinsonism, 409 (75.5%) were classified as proteinopathies. Of the 389 patients with presumed synucleinopathies (71.8%), 264 had Parkinson disease (48.7% of all cases). The incidence rate of synucleinopathies was 21.0 per 100 000 person-years overall and increased steeply with age. The incidence rate of tauopathies was 1.1 overall (20 cases), and the most common tauopathy was progressive supranuclear palsy (16 cases). Thirty-six subjects had drug-induced parkinsonism (6.6%), 11 had vascular parkinsonism (2.0%), 1 had amyotrophic lateral sclerosis in parkinsonism (0.2%), 1 had parkinsonism secondary to surgery (0.2%), and 84 remained unspecified (15.5%). Men had a higher incidence than women for most types of parkinsonism. Findings at brain autopsy confirmed the clinical diagnosis in 53 of 65 patients who underwent autopsy (81.5%). <h3>Conclusions and Relevance</h3> The incidence of proteinopathies related to parkinsonism increases steeply with age and is consistently higher in men than women. Clinically diagnosed synucleinopathies are much more common than tauopathies. Findings at autopsy confirm the clinical diagnosis of presumed proteinopathy. Our findings may guide health care planning and prompt new research directions.
Effect of interventions on children's blood lead levels.
Authors: S R Hilts, S E Bock, T L Oke, C L Yates, R A Copes
Journal: Environmental Health Perspectives (1998)

Trail, Canada, has been the site of an active lead/zinc smelter for nearly a century. Since 1991, the Trail Community Lead Task Force has carried out blood lead screening, case management, education programs targeted at early childhood groups and the general community, community dust abatement, exposure pathways studies, and remedial trials. From 1989 through 1996, average blood lead levels of children tested for the first time declined at an average rate of 0.6 microg/dl/year, while blood lead levels in Canadian children not living near point sources appeared to be leveling off following the phase-out of leaded gasoline. Since there was no concurrent improvement in local environmental conditions during this time, it is possible that the continuing decline in Trail blood lead levels has been at least partly due to community-wide intervention programs. One year follow-up of children whose families received in-home educational visits, as well as assistance with home-based dust control measures, found that these specific interventions produced average blood lead changes of +0.5- -4.0 microg/dl, with statistically significant declines in 3 years out of 5. Education and dust control, particularly actions targeted toward higher risk children, appear to have served as effective and appropriate interim remedial measures while major source control measures have been implemented at the smelter site.
Management of Abruptio Placentae
Authors: Ira M. Golditch
Journal: JAMA (1970)

Analyzing 130 cases of abruptio placentae among 26,743 deliveries (1:206), the authors conclude that effective management depends primarily on early recognition of the high-risk patient, immediate hospitalization of all women with third trimester bleeding, prompt institution of liberal whole blood replacement, and early definitive diagnosis. Except when hemorrhage can not be controlled, vaginal delivery should be expected after amniotomy and oxytocin stimulation in mild cases, or if the fetus has died in utero. In moderate and severe cases, if vaginal delivery is not imminent, the viable fetus probably will not survive unless cesarean section is performed as soon as blood replacement has been started and any existing coagulopathy has been corrected.
Primary cutaneous T-cell-rich B-cell lymphoma
Authors: E. ARAI, M. SAKURAI, H. NAKAYAMA, S. MORINAGA, I. KATAYAMA
Journal: British Journal of Dermatology (1993)

Journal Article Primary cutaneous T‐cell‐rich B‐cell lymphoma Get access E. ARAI, E. ARAI First Department of Pathology, Saitama Medical School, Saitama, Japan Search for other works by this author on: Oxford Academic Google Scholar M. SAKURAI, M. SAKURAI Division of Dermatology, Tokyo Saiselkal Chuo Hospital, Tokyo, Japan Search for other works by this author on: Oxford Academic Google Scholar H. NAKAYAMA, H. NAKAYAMA Division of Dermatology, Tokyo Saiselkal Chuo Hospital, Tokyo, Japan Search for other works by this author on: Oxford Academic Google Scholar S. MORINAGA, S. MORINAGA Division of Pathology, Tokyo Saiselkal Chuo Hospital, Tokyo, Japan Search for other works by this author on: Oxford Academic Google Scholar I. KATAYAMA I. KATAYAMA First Department of Pathology, Saitama Medical School, Saitama, Japan Correspondece: Dr. I. Katayama, First Department of Pathology, Saitama Medical School, 38 Morohongo, Moroyama‐machi, Saitama 350–04, Japan. Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 129, Issue 2, 1 August 1993, Pages 196–200, https://doi.org/10.1111/j.1365-2133.1993.tb03529.x Published: 01 August 1993 Article history Accepted: 05 June 1991 Published: 01 August 1993
Abstract ES08-2: Predicting tumor response by functional imaging, PET imaging as a functional predictive biomarker
Authors: D Mankoff
Journal: Cancer Research (2013)

Abstract The ability to measure biochemical and molecular processes to guide breast cancer treatment represents a significant advance in individualized breast cancer treatment. These assays have traditionally been performed by analysis of cell culture or tissue samples. More recently, functional and molecular imaging allows in vivo assay of biochemistry and molecular biology that is highly complementary to tissue-based assay. Molecular imaging can help inform drug trial of targeted breast cancer treatment and clinical decision making by (1) measuring regional expression of the therapeutic target, (2) testing the ability of drugs to interact with their intended targets, and (3) by measuring cancer response early in the course of treatment. This talk will review basic principals of molecular imaging in breast cancer, with an emphasis on those methods that have been tested in patients. The talk will review the current state of molecular imaging in breast cancer patients, including methods in routine clinical use, those undergoing advanced clinical trials, and those in early-phase testing. Current trials and future directions will be highlighted. The session is designed for a broad audience, ranging from breast cancer translational scientists to practicing physicians caring for breast cancer patients. References 1. Mankoff DA. Molecular imaging as a tool for translating breast cancer science. Breast Cancer Res. 2008;10 Suppl 1:S3. 2. Specht JM, Mankoff DA. Advances in molecular imaging for breast cancer detection and characterization. Breast Cancer Res. 2012 Mar 16;14(2):206. Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr ES08-2.
Effects of Drugs on Small Airways
Authors: ANN J. WOOLCOCK
Journal: American Journal of Respiratory and Critical Care Medicine (1998)

Little is known about the effects of drugs on small airways. However, the small airways respond to constricting and dilating substances in vitro. Pathologic assessment demonstrates that small airways are inflamed, and the physiology suggests that they narrow and dilate. If after a period of treatment for asthma, all tests including the SBNT are normal, it would be safe to say that the small airways had been treated. However, we need to have some way of imaging the airways to decide whether or not there is abnormality in the small airways and to target the drugs that we are using to treat them. New ways of imaging, measuring, and performing a biopsy of the small airways are needed if we are going to make progress in this area.
Acquired immunodeficiency syndrome cause(s) still elusive
Authors: C. Macek
Journal: JAMA (1982)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: U.S. Preventive Services Task Force Recommendation Statement
Authors: Virginia A. Moyer
Journal: Annals of Internal Medicine (2013)

Chinese translation Description: Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation statement on hormone therapy for the prevention of chronic conditions in postmenopausal women. Methods: The USPSTF commissioned a review of the literature to update evidence about the benefits and harms of using menopausal hormone therapy to prevent chronic conditions, as well as whether the benefits and harms of hormone therapy differ by population subgroups defined by age; the presence of comorbid medical conditions; and the type, dose, and method of hormonal delivery. Population: This recommendation applies to postmenopausal women who are considering hormone therapy for the primary prevention of chronic medical conditions. It does not apply to women who are considering hormone therapy for the management of menopausal symptoms, such as hot flashes or vaginal dryness. It also does not apply to women younger than 50 years who have had surgical menopause. Recommendation: The USPSTF recommends against the use of combined estrogen and progestin for the prevention of chronic conditions in postmenopausal women. (Grade D recommendation). The USPSTF recommends against the use of estrogen for the prevention of chronic conditions in postmenopausal women who have had a hysterectomy. (Grade D recommendation).
A New Editor for <i>Annals of Internal Medicine</i>—2001
Authors: Eric B. Larson
Journal: Annals of Internal Medicine (2001)

Editorials5 June 2001A New Editor for Annals of Internal Medicine—2001Eric B. Larson, MD, MPHEric B. Larson, MD, MPHDr. Larson: Chair, Publications Committee; Board of Regents, American College of Physicians–American Society of Internal Medicine; Philadelphia, PA 19106Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-134-11-200106050-00015 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Since its founding 74 years ago, originally as the Journal of the American College of Physicians, Annals of Internal Medicine has risen to a lofty position. Worldwide, it is the top internal medicine journal and is ranked fourth in citation frequency among all general medical journals. Members of the American College of Physicians–American Society of Internal Medicine (ACP–ASIM) consistently cite Annals as the most important benefit of College membership. Annals is arguably, therefore, the flagship of the College.The 3 July 2001 issue of Annals will witness a changing of the guard. Frank Davidoff will exit gracefully after 6.5 years ... Author, Article, and Disclosure InformationAffiliations: Dr. Larson: Chair, Publications Committee; Board of Regents, American College of Physicians–American Society of Internal Medicine; Philadelphia, PA 19106Corresponding Author: Eric B. Larson, MD, MPH, University of Washington Medical Center, Medical Director, Box 356330, Seattle, WA 98195. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited bySmdm Presidential Address: Hearsay or Heresy—Are Health Decision Scientists Too Left Brained? 5 June 2001Volume 134, Issue 11Page: 1072-1073KeywordsEpidemiological methods and statisticsForecastingHealth careInternetPatientsScientists ePublished: 5 June 2001 Issue Published: 5 June 2001 Copyright & PermissionsCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
High court rejects challenge to NICE guidelines on chronic fatigue syndrome
Authors: C. Dyer
Journal: BMJ (2009)

A legal challenge to guidance that recommends that NHS patients with chronic fatigue syndrome should be treated with cognitive behavioural therapy and graded exercise therapy has been rejected by the High Court in London.

The judge, Mr Justice Simon, expressed concern at allegations by the two patients who brought the action that experts who had helped formulate the guidelines were biased against other types of treatments and had approached the exercise with closed minds.

He said the “unfounded” claims were “damaging to those against whom they were made and were such as may cause health professionals to hesitate before they involve themselves in this area of medicine.”

He added, “A perception that this is an area of medicine where contrary …
Genetic screening in adolescents with steroid-resistant nephrotic syndrome
Authors: Beata S. Lipska, Paraskevas Iatropoulos, Ramona Maranta, Gianluca Caridi, Fatih Ozaltin, Ali Anarat, Ayse Balat, Jutta Gellermann, Agnes Trautmann, Ozlem Erdogan, Bassam Saeed, Sevinc Emre, Radovan Bogdanovic, Marta Azocar, Irena Balasz-Chmielewska, Elisa Benetti, Salim Caliskan, Sevgi Mir, Anette Melk, Pelin Ertan, Esra Baskin, Helena Jardim, Tinatin Davitaia, Anna Wasilewska, Dorota Drozdz, Maria Szczepanska, Augustina Jankauskiene, Lina Maria Serna Higuita, Gianluigi Ardissino, Ozan Ozkaya, Elzbieta Kuzma-Mroczkowska, Oguz Soylemezoglu, Bruno Ranchin, Anna Medynska, Marcin Tkaczyk, Amira Peco-Antic, Ipek Akil, Tomasz Jarmolinski, Agnieszka Firszt-Adamczyk, Jiri Dusek, Giacomo D. Simonetti, Faysal Gok, Alaleh Gheissari, Francesco Emma, Rafael T. Krmar, Michel Fischbach, Nikoleta Printza, Eva Simkova, Caterina Mele, Gian Marco Ghiggeri, Franz Schaefer
Journal: Kidney International (2013)
THE LANGUAGE OF HEALTH CARE: The alienating language of health care
Authors: Peter Davies
Journal: Journal of the Royal Society of Medicine (2007)

Please e-mail letters for publication to Dr Kamran Abbasi [ kamran.abbasi@rsm.ac.uk ]. Letters should be no longer than 300 words and preference will be given to letters responding to articles published in the JRSM. Our aim is to publish letters quickly. Not all correspondence will be acknowledged.
Junior doctors' reaction to 48 hour limit
Authors: A. R Thornley, P. Maguire, R. Moorthy
Journal: BMJ (2008)

In their editorial on the European Working Time Directive, Cairns et al incorrectly say that the SiMAP judgment applies to both resident and non-resident time on call when it specifically relates to time spent resident on call.1 2

Junior doctors are justifiably …
Ireland considers compulsory health insurance for all and subsidised premiums for least well off
Authors: M. Houston
Journal: BMJ (2014)

Free GP care for all and a move to an insurance based rather than a taxation based funding model are among major changes to the Irish health system signalled in a white paper that the government published last week.1

The prime minister, Enda Kenny, and the minister for health, James Reilly, unveiled plans to create a one tier health system, with access based on need rather than the ability to pay. At present some 40% of the Irish population are eligible for free healthcare, based on …
Cancer Risk in Diet Supplement
Authors: Rebecca Voelker
Journal: JAMA (1999)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Commentary: Metal on metal hips
Authors: J. Skinner, P. Kay
Journal: BMJ (2011)

Total hip replacement is one of the most successful operations of the 20th century and is currently performed in 70 000 patients a year in the UK,1 250 000 a year in the United States, and one million worldwide. In an attempt to improve wear resistance and to allow bone conservation through hip resurfacing, metal on metal bearings were re-introduced in the 1990s.2. These are made of cobalt chromium alloys, and in some series metal hip resurfacing has shown excellent results in the younger and most active patient groups.3 Several other designs were introduced, and hip resurfacing became popular with patients through the internet as a younger person’s solution to arthritis that allowed high activity levels. It was used in 10% of hip arthroplasties in the UK between 2006 and 2009 and in 50% of all hip replacements in patients younger than 50 years.1

Problems with hip resurfacing that were initially reported included raised blood cobalt and chromium ions,4 loosening of components,5 hip fracture,6 and soft tissue reactions around the hip.7 In an attempt to overcome the fracture problem and to extend the use of large diameter metal on metal bearings to those not suitable for hip resurfacing, metal resurfacing type bearings were introduced on total hip replacement stems.8 These large diameter metal on metal total hip replacements had a lower theoretical rate of dislocation. In fact, metal on metal bearings were used in up to 35% of all total hip replacements in the United States in 2009.9

The commonest symptoms of adverse reactions to metal debris are pain, swellings around the hip, …
A Double-Blind Placebo–Controlled, Multicenter, Cross-Over, Dose-Ranging Study to Compare the Efficacy and Safety of Albuterol Spiromax and Proair HFA in Adult and Adolescent Patients Ages 12 and Older with Persistent Asthma
Authors: Edward M. Kerwin, Herminia Taveras, Harald Iverson, Denise Wayne, Tushar Shah, Mark S. Lepore
Journal: Journal of Allergy and Clinical Immunology (2013)